SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $138,152,113 |
| Positions | 54 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| CVS HEALTH CORP | CVS | COM | $5,738,889 | 55,475 |
| BIOGEN INC | BIIB | COM | $5,183,928 | 23,993 |
| DUPONT DE NEMOURS INC | DD | COMMON STOCK | $5,119,732 | 37,745 |
| WARNER BROS DISCOVERY INC | WBD | COM SER A | $5,065,027 | 189,986 |
| BAXTER INTL INC | BAX | COM | $5,032,202 | 236,032 |
| INTERNATIONAL FLAVORS&FRAGRA | IFF | COM | $4,980,958 | 62,875 |
| GSK PLC | GSK | SPONSORED ADR | $4,842,717 | 92,383 |
| CARMAX INC | KMX | COM | $4,833,353 | 91,385 |
| BOEING CO | BA | COM | $4,670,124 | 21,574 |
| ZIMMER BIOMET HOLDINGS INC | ZBH | COM | $4,643,953 | 53,943 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.